Allergy and Asthma Specialist

Owensboro, Kentucky 42301

1 studies enrolling now · 2 studies all time

What they study most

Atopic Dermatitis, Eczema

Studies at this site

• A Study to Assess the Long-Term Safety and Efficacy of Lebrikizumab (LY3650150) in Participants 6 Months to <18 Years of Age With Moderate-to-Severe Atopic Dermatitis — Enrolling by invitation
• A Study of LY3454738 in the Treatment of Adult Participants With Moderate-to-Severe Atopic Dermatitis — Stopped early